Stason Pharmaceuticals, Inc.
11 Morgan
Irvine
California
92618-4327
United States
Tel: 949-380-4327
Fax: 949-380-4345
Website: http://www.stasonpharma.com/
8 articles about Stason Pharmaceuticals, Inc.
-
Stason Pharmaceuticals, Inc. Announces Kansas City Expansion, Adds Human Health Capabilities
11/11/2013
-
Amerigen Pharmaceuticals and Stason Pharmaceuticals, Inc. Enter Into Collaboration Agreement for Development of Generic Oral Oncology Products
10/18/2011
-
Stason Pharmaceuticals, Inc. and Lonza Inc. Sign Agreement to License the GS Gene Expression System(TM) to Develop and Manufacture TNT Antibodies
12/16/2010
-
Peregrine Pharmaceuticals, Inc. and Stason Pharmaceuticals, Inc. Enter Into Agreement for Innovative Tumor Necrosis Therapy (TNT) Technologies
5/3/2010
-
Unilife Medical Solutions and Stason Pharmaceuticals, Inc. Sign Asian Distribution Agreement for the Unitract(TM) 1mL Safety Syringe
3/10/2010
-
Abingdon Life Sciences, Inc. Extends Strategic Alliance With Stason Pharmaceuticals, Inc. to Provide Regulatory and Clinical Support to Asian Pharmaceutical and Biotech Companies
11/17/2008
-
Abingdon Life Sciences, Inc. Enters Into Strategic Alliance With Stason Pharmaceuticals, Inc. to Provide Regulatory and Clinical Support
8/4/2008
-
Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
6/24/2008